Mutations in genes in the NF-κB pathway were observed in 1 of 31 MM samples, which indicates that moderate NF-κB signaling activation by transgenic IKK2 expression in heterozygosity is enough for the development of precursor stages, which progress into MM without additional changes in the pathway. The gene discussed is NFKB1; the disease is Miyoshi myopathy.